Precipio Inc (PRPO) reports positive cash flow and revenue growth, while addressing challenges in its product division and ...

Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update ...

We've identified the following companies as similar to Laboratory Corporation of America because they operate in a related industry or sector. We also considered size, growth, and various financial ...

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31 st, ...

Precipio (PRPO), has achieved two financial goals in the last quarter of 2024: Positive Adjusted EBITDA – Precipio reports Adjusted EBITDA of $0.4M for Q4-2024. Adjusted EBITDA is a non-GAAP metric ...

Positive Adjusted EBITDA – Precipio reports (unaudited) Adjusted EBITDA of $0.4M for Q4-2024. Adjusted EBITDA is a non-GAAP metric that comprises EBITDA, less non-cash stock-based compensation expense ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that it has achieved two important financial goals in the last ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it has achieved two important financial goals in the last quarter ...